Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I–III pancreatic ductal adenocarcinoma: a retrospective cohort study

Neoadjuvant therapy remains controversial in treating resectable pancreatic ductal adenocarcinoma (PDAC) patients. This study aims to assess the impact of neoadjuvant therapy on survival in patients with PDAC according to their clinical stage. METHODS: Patients with resected clinical Stage I–III PDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yiping, Gao, Song, Yu, Xin, Zhou, Tianxing, Xie, Yongjie, Guo, Xiaofan, An, Ran, Wang, Xiuchao, Zhao, Tiansuo, Chang, Antao, Gao, Chuntao, Yu, Jun, Hao, Jihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389558/
https://www.ncbi.nlm.nih.gov/pubmed/37132194
http://dx.doi.org/10.1097/JS9.0000000000000425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389558/
https://www.ncbi.nlm.nih.gov/pubmed/37132194
http://dx.doi.org/10.1097/JS9.0000000000000425

Ejemplares similares